Skip to main content

Tyrosine-Protein Phosphatase Nonreceptor Type 11 (PTPN11)

  • Reference work entry
  • First Online:

Synonyms

BPTP3; CFC; NS1; Protein tyrosine phosphatase 1D; Protein tyrosine phosphatase 2C; Protein tyrosine phosphatase-2; Protein tyrosine phosphatase, nonreceptor type 11; PTP-1D; PTP2C; PTP-2C; PTPN11; SHP2; Shp2; SHP-2; SHPTP2; SH-PTP2; SH-PTP3; Tyrosine-protein phosphatase nonreceptor type 11

Historical Background

Src homology 2-containing protein tyrosine phosphatase (SHP2, also known as PTPN11) is a member of the non-receptor-type protein tyrosine phosphatase (PTP) family and is encoded by PTPN11gene. In the early 1990s, this PTP was identified on the basis of its sequence similarity to the catalytic domain of known PTPs. PTPs dephosphorylate tyrosine-phosphorylated proteins, which generally promote cellular events such as cell growth, differentiation, migration, adhesion, and apoptosis. Therefore, PTPs are considered to be negative regulators in intracellular signal transductions. However, biochemical and genetic analyses in 1990s showed that SHP2 promotes the activation of...

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   4,499.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   4,499.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  • Allard JD, Chang HC, Herbst R, McNeill H, Simon MA. The SH2-containing tyrosine phosphatase corkscrew is required during signaling by sevenless, Ras1 and Raf. Development. 1996;122:1137–46.

    PubMed  CAS  Google Scholar 

  • Araki T, Mohi MG, Ismat FA, Bronson RT, Williams IR, Kutok JL, et al. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation. Nat Med. 2004;10:849–57. doi:10.1038/nm1084.

    Article  PubMed  CAS  Google Scholar 

  • Bentires-Alj M, Gil SG, Chan R, Wang ZC, Wang Y, Imanaka N, et al. A role for the scaffolding adapter GAB2 in breast cancer. Nat Med. 2006;12:114–21. doi:10.1038/nm1341.

    Article  PubMed  CAS  Google Scholar 

  • Chan RJ, Leedy MB, Munugalavadla V, Voorhorst CS, Li Y, Yu M, et al. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor. Blood. 2005;105:3737–42. doi:10.1182/blood-2004-10-4002.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Chen YN, LaMarche MJ, Chan HM, Fekkes P, Garcia-Fortanet J, Acker MG, et al. Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases. Nature. 2016;535:148–52. doi:10.1038/nature18621.

    Article  PubMed  CAS  Google Scholar 

  • Gauthier AS, Furstoss O, Araki T, Chan R, Neel BG, Kaplan DR, et al. Control of CNS cell-fate decisions by SHP-2 and its dysregulation in Noonan syndrome. Neuron. 2007;54:245–62. doi:10.1016/j.neuron.2007.03.027.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Gutch MJ, Flint AJ, Keller J, Tonks NK, Hengartner MO. The Caenorhabditis elegans SH2 domain-containing protein tyrosine phosphatase PTP-2 participates in signal transduction during oogenesis and vulval development. Genes Dev. 1998;12:571–85.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hatakeyama M, Higashi H. Helicobacter pylori CagA: a new paradigm for bacterial carcinogenesis. Cancer Sci. 2005;96:835–43. doi:10.1111/j.1349-7006.2005.00130.x.

    Article  PubMed  CAS  Google Scholar 

  • Heuberger J, Kosel F, Qi J, Grossmann KS, Rajewsky K, Birchmeier W. Shp2/MAPK signaling controls goblet/Paneth cell fate decisions in the intestine. Proc Natl Acad Sci U S A. 2014;111:3472–7. doi:10.1073/pnas.1309342111.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE. Crystal structure of the tyrosine phosphatase SHP-2. Cell. 1998;92:441–50.

    Article  PubMed  CAS  Google Scholar 

  • Ke Y, Zhang EE, Hagihara K, Wu D, Pang Y, Klein R, et al. Deletion of Shp2 in the brain leads to defective proliferation and differentiation in neural stem cells and early postnatal lethality. Mol Cell Biol. 2007;27:6706–17. doi:10.1128/MCB.01225-07.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kontaridis MI, Yang W, Bence KK, Cullen D, Wang B, Bodyak N, et al. Deletion of Ptpn11 (Shp2) in cardiomyocytes causes dilated cardiomyopathy via effects on the extracellular signal-regulated kinase/mitogen-activated protein kinase and RhoA signaling pathways. Circulation. 2008;117:1423–35. doi:10.1161/CIRCULATIONAHA.107.728865.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Kusakari S, Saitow F, Ago Y, Shibasaki K, Sato-Hashimoto M, Matsuzaki Y, et al. Shp2 in forebrain neurons regulates synaptic plasticity, locomotion, and memory formation in mice. Mol Cell Biol. 2015;35:1557–72. doi:10.1128/MCB.01339-14.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lechleider RJ, Sugimoto S, Bennett AM, Kashishian AS, Cooper JA, Shoelson SE, et al. Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor. J Biol Chem. 1993;268:21478–81.

    PubMed  CAS  Google Scholar 

  • Milarski KL, Saltiel AR. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J Biol Chem. 1994;269:21239–43.

    PubMed  CAS  Google Scholar 

  • Mohi MG, Williams IR, Dearolf CR, Chan G, Kutok JL, Cohen S, et al. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations. Cancer cell. 2005;7:179–91. doi:10.1016/j.ccr.2005.01.010.

    Article  PubMed  CAS  Google Scholar 

  • Noguchi T, Matozaki T, Horita K, Fujioka Y, Kasuga M. Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation. Mol Cell Biol. 1994;14:6674–82.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Pluskey S, Wandless TJ, Walsh CT, Shoelson SE. Potent stimulation of SH-PTP2 phosphatase activity by simultaneous occupancy of both SH2 domains. J Biol Chem. 1995;270:2897–900.

    Article  PubMed  Google Scholar 

  • Saxton TM, Henkemeyer M, Gasca S, Shen R, Rossi DJ, Shalaby F, et al. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. EMBO J. 1997;16:2352–64. doi:10.1093/emboj/16.9.2352.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sugimoto S, Wandless TJ, Shoelson SE, Neel BG, Walsh CT. Activation of the SH2-containing protein tyrosine phosphatase, SH-PTP2, by phosphotyrosine-containing peptides derived from insulin receptor substrate-1. J Biol Chem. 1994;269:13614–22.

    PubMed  CAS  Google Scholar 

  • Tang TL, Freeman Jr RM, O’Reilly AM, Neel BG, Sokol SY. The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development. Cell. 1995;80:473–83.

    Article  PubMed  CAS  Google Scholar 

  • Tartaglia M, Gelb BD. Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet. 2005;6:45–68. doi:10.1146/annurev.genom.6.080604.162305.

    Article  PubMed  CAS  Google Scholar 

  • Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, et al. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29:465–8. doi:10.1038/ng772.

    Article  PubMed  CAS  Google Scholar 

  • Tsutsumi R, Masoudi M, Takahashi A, Fujii Y, Hayashi T, Kikuchi I, et al. YAP and TAZ, Hippo signaling targets, act as a rheostat for nuclear SHP2 function. Dev Cell. 2013;26:658–65. doi:10.1016/j.devcel.2013.08.013.

    Article  PubMed  CAS  Google Scholar 

  • Yamashita H, Kotani T, Park JH, Murata Y, Okazawa H, Ohnishi H, et al. Role of the protein tyrosine phosphatase Shp2 in homeostasis of the intestinal epithelium. PloS One. 2014;9:e92904. doi:10.1371/journal.pone.0092904.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yamauchi K, Milarski KL, Saltiel AR, Pessin JE. Protein-tyrosine-phosphatase SHPTP2 is a required positive effector for insulin downstream signaling. Proc Natl Acad Sci U S A. 1995;92:664–8.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Yang W, Klaman LD, Chen B, Araki T, Harada H, Thomas SM, et al. An Shp2/SFK/Ras/Erk signaling pathway controls trophoblast stem cell survival. Dev Cell. 2006;10:317–27. doi:10.1016/j.devcel.2006.01.002.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Takenori Kotani or Takashi Matozaki .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Kotani, T., Murata, Y., Saito, Y., Matozaki, T. (2018). Tyrosine-Protein Phosphatase Nonreceptor Type 11 (PTPN11). In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, Cham. https://doi.org/10.1007/978-3-319-67199-4_101832

Download citation

Publish with us

Policies and ethics